Astragaloside IV Enhances Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via PINK1 /Parkin Pathway
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Lin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key TCM Laboratory for Chinese Resource Innovation and Transformation, Zhejiang Provincial International S&T Cooperation Base for Active Ing…. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Reperfusion Injury, Mitophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Science and Technology Department of National Administration of Traditional Chinese Medicine and Zhejiang Administration of Traditional Chinese Medicine, Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project.
Abstract (Originalsprache)
Astragaloside IV (AS‐IV), a primary bioactive component of Astragalus membranaceus (AM). It is very effective in regulating renal diseases. However, the possible underlying mechanism of AS‐IV on renoprotection remains unclear. The aim of this study is to find out the regulation mechanism of AS‐IV on ischemia/reperfusion injury‐induced Acute kidney injury (IRI‐AKI). At first, AS‐IV was confirmed to significantly alleviate renal dysfunction, inflammation, and renal tubular epithelial cell apoptosis in IRI‐AKI mice. Then, it was found that AS‐IV alleviated mitochondrial dysfunction and renal tubular epithelial cell injury induced by IRI. Growing evidence has suggested that PINK1/Parkin‐mediated mitophagy plays a critical protective role in IRI. Based on this, we hypothesized that AS‐IV might exert renoprotective effects through activating the PINK1/Parkin mitophagy pathway. After 3‐MA inhibition of autophagy, AS‐IV no longer showed its protective effect on HK‐2 cells in a hypoxic environment. Through further molecular docking, cell thermal migration, and gene targeted silencing experiments, we confirmed that AS‐IV activates the PINK1/Parkin mitophagy pathway and ultimately alleviates IRI‐AKI. In summary, all these comprehensive experimental findings indicated that AS‐IV can be used as a functional food for the prevention of renal ischemia/reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key TCM Laboratory for Chinese Resource Innovation and Transformation, Zhejiang Provincial International S&T Cooperation Base for Active Ingredients of Medicinal and Edible Plants and Health, School of Pharmace…
ORCID-Profile: Guoyin Kai
Förderung
- National Natural Science Foundation of China
- The Science and Technology Department of National Administration of Traditional Chinese Medicine and Zhejiang Administration of Traditional Chinese Medicine
- Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project
- Chunyan Traditional Chinese Medicine Development Special Fund
- Provincial 2025 "Lingyan" Science and Technology Project
- Jinhua Municipal Major Research Project on Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province
- Jinhua Major Science and Technology Project of Zhejiang Province
Zitieren
APA
Liu, L., Xu, Z., Wu, S., Li, M., Wei, R., Sitholumusa, M. U. I., Liu, J., & Kai, G. (2026). Astragaloside IV Enhances Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via PINK1 /Parkin Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.70369
Vancouver
Liu L, Xu Z, Wu S, Li M, Wei R, Sitholumusa MUI, et al. Astragaloside IV Enhances Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via PINK1 /Parkin Pathway. Phytotherapy Research. 2026. doi:10.1002/ptr.70369
BibTeX
@article{Liu2026,
author = {Liu, Lin and Xu, Zonghui and Wu, Shujing and Li, Man and Wei, Ruoan and Sitholumusa, Mpofu Uphakeme Inobubele and Liu, Junqiu and Kai, Guoyin},
title = {Astragaloside IV Enhances Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via PINK1 /Parkin Pathway},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70369}
}
EUVIMED